Format

Send to

Choose Destination
Clin Neurol Neurosurg. 2017 Sep;160:101-104. doi: 10.1016/j.clineuro.2017.07.003. Epub 2017 Jul 5.

Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson's disease, especially on bradykinesia.

Author information

1
Department of Neurology, Beijing Hospital, National Center of Gerontology. No.1 DaHua Road, Dong Dan, Beijing, China. Electronic address: liuhuijing.2007@163.com.
2
Department of Neurology, Beijing Hospital, National Center of Gerontology. No.1 DaHua Road, Dong Dan, Beijing, China. Electronic address: suwendy@126.com.
3
Department of Neurology, Beijing Hospital, National Center of Gerontology. No.1 DaHua Road, Dong Dan, Beijing, China.
4
Department of Neurology, Beijing Hospital, National Center of Gerontology. No.1 DaHua Road, Dong Dan, Beijing, China. Electronic address: raindw@126.com.
5
Department of Neurology, Beijing Hospital, National Center of Gerontology. No.1 DaHua Road, Dong Dan, Beijing, China. Electronic address: likai_bjh@hotmail.com.
6
Department of Neurology, Beijing Hospital, National Center of Gerontology. No.1 DaHua Road, Dong Dan, Beijing, China. Electronic address: chenhb_bjh@hotmail.com.

Abstract

OBJECTIVES:

Previous studies have shown that Helicobacter pylori infection might make clinical status worse in patients with Parkinson's disease and Helicobacter pylori eradication might improve clinical status by modifying the pharmacokinetics of L-dopa. Here, we investigate whether Helicobacter pylori eradication could benefit idiopathic parkinsonism and Helicobacter pylori infection will effect which aspect of motor symptom significantly.

PATIENTS AND METHODS:

A cohort study involving idiopathic Parkinson's disease patients, screened for Helicobacter status by 13C urea breath test. Clinical status was evaluated by using the Unified Parkinson's Disease Rating Scale (UPDRS) and Hoehn-Yahr stage. If patients had motor complications, they were quantified at the "on" time. The Helicobacter pylori positive patients could choose to receive Helicobacter pylori eradication or not by themselves. Group 1 was Helicobacter pylori negative patients. Group 2 was Helicobacter pylori positive patients who didn't receive eradication treatment. Group 3 was Helicobacter pylori positive patients who received successful eradication treatment. Repeat clinical assessments and 13C urea breath test was performed at 1year later. Numerical data were expressed as mean±standard deviation (SD) RESULTS: Ninety-four consecutive patients with Parkinson's disease were recruited and underwent the initial 13C urea breath test, but only forty-eight patients successfully completed the total study. In Group 3, the UPDRS-III scores (=Motor Examination Section Scores) were significantly lower 1year later compared to baseline (18.3±8.38 vs. 25.9±8.37, P=0.007). The differences were main in UPDRS-23 (=Finger Taps) (1.7±1.16 vs. 2.4±1.51, P=0.045), UPDRS-25 (Rapid Alternation Movements of Hands) (1.6±1.35 vs. 2.4±1.71, P=0.031) and UPDRS-26 (=Leg Agility) (1.3±1.25 vs.2.1±0.99, P=0.011). There was difference among three groups in the UPDRS-26 (P=0.040) of clinical status change of one year.

CONCLUSION:

The eradication of Helicobacter might improve the clinical status of idiopathic parkinsonism, especially on bradykinesia.

KEYWORDS:

Bradykinesia; Eradication; Helicobacter pylori; Parkinson’s disease

PMID:
28704778
DOI:
10.1016/j.clineuro.2017.07.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center